[Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
Diabetes treatment with continuous insulin infusion with the use of personal insulin pumps secures strict metabolic control in diabetes--patients and can minimize a number of complications of diabetes. According to American Diabetes Association (2001), diabetes therapy with continuous insulin infusion is recommended for each person, who accept this therapy method. Personal insulin pump is well tolerated device, which enables to conduct a comfortable continuous insulin infusion. The patients, who comply with medical instruction and perform self-monitoring are fit for diabetes treatment with personal insulin pump. According to present recommendation, there is not necessary to hospitalize patients to initiate continuous insulin infusion. Treatment with personal insulin pump takes up in Poland only in wards of Diabetology and Diabetes outpatient clinics. The main indications of personal insulin pump use are: unstable course of diabetes despite of the another intensive insulin methods used before, often hypoglycemic episodes in anamnesis, active, changing patient's life-style. Little daily insulin requirement < 20 U.l./24 hours, pregnancy. The essential advantages in personal insulin pump use are: prompt metabolic control improvement, a considerable liberty in meal consumption (in its time and amount) and intensity of effort, decrease in number of hypoglycemia and exactly insulin dosage establishment.
Mozdzan
Michał
M
Klinika Diabetologii IMW Uniwersytetu Medycznego w Lodzi. mozdzanm@poczta.onet.pl
Ruxer
Jan
J
Loba
Jerzy
J
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007003:Hypoglycemia / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D015918:Infusion Pumps, Implantable; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D011044:Poland
D007004:Hypoglycemic Agents; D007328:Insulin